News

EANS-News: Marinomed Biotech AG / Marinomed announces its intention to launch an Initial Public Offering and listing on the Vienna Stock Exchange

ACIB: Targeting cancer

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

Valneva Receives Positive Feedback from EMA on its further Development for Lyme Disease Vaccine VLA15

Valneva Announces Progress of Chikungunya Vaccine

Themis Bioscience Announces Exclusive Licensing Agreement with Max- Planck-Innovation to Develop and Commercialize Oncolytic Virotherapies Themis to expand measles vector immunomodulation portfolio into oncology indications

Nanocages in the lab and in the computer: how DNA-based dendrimers transport nanoparticles

TÜV AUSTRIA Wissenschaftspreis-Shortlist 2018 Die Kandidaten für den diesjährigen Wissenschaftspreis stehen fest

Award for Emmanuelle Charpentier

Roche joins the EHC PARTNERS programme

Valneva Announces FDA Approval of Accelerated IXIARO® Vaccination Schedule

Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors

Roche signs collaboration agreement to expand access to therapy information by integrating insulin data from connected pens to its open ecosystem

Fruit flies adapt to climate change through metabolic rewiring

APEIRON Announces Collaboration with Lead Discovery Center GmbH

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases

Tracing the footprints of a tumor: genomic “scars” allow cancer profiling

AFFiRiS Announces Encouraging Long-term Data from a Series of First-in-Human Studies Using AFFITOPE® PD01A Targeting Oligomeric Alpha-synuclein in Early Parkinson’s Disease Patients

Leonid Sazanov elected member of EMBO